| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8243511 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 7 Pages |
Abstract
Conclusion: Treated with neoadjuvant chemotherapy RIO seem to have an outcome that is not significantly different from that of comparable patients with conventional primary high grade osteosarcoma (5-year event-free survival: 40% vs. 60%, p = NS; 5-year overall survival 40% vs. 67%, p < 0.01).
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Gaetano M.D., Alessandra M.D., Cristiana R.N., Nicola M.D., Antonio M.D., Enza M.D., Mario M.D., Alba B.A., Stefano M.D., Piero M.D.,